Pressure Ulcers Market Research, 2031
The global pressure ulcers market size was valued at $3.7 billion in 2021, and is projected to reach $5.6 billion by 2031, growing at a CAGR of 4.2% from 2022 to 2031. Pressure ulcers are also called as bed sores, pressure sores or decubitus ulcer are injuries to the skin and tissue due to prolonged pressure or pressure with friction on the skin. Pressure ulcers occurs most commonly on the skin present over sacrum, heels, hips and coccyx. The other affected sites are knees, elbows, ankles and back of cranium. Pressure ulcers market include the sales of medication that are used to treat pressure ulcer conditions.
The pressure ulcers market driven by increase in prevalence of pressure ulcer, rise in geriatric population as they are more susceptible to develop pressure ulcers, rise in awareness about availability of treatments for pressure ulcers, and increase in demand for wound care dressings product boost the growth of the market during forecast period. For instance, according to the U.S. Department of Health and Human Wound Care Dressings, around 2.5 million population of the U.S was affected by pressure ulcers in 2020. Moreover, according to Wound Management and Prevention, about 71% pressure ulcers develop in patients older than 70 years.
However, high cost of treatments and side effects associated with the drug treatments such as upset stomach, nausea and blood pressure hinder the market growth. On the other side, increase in demand of pressure ulcers treatment will create pressure ulcers market opportunity.
The global pressure ulcers market is segmented into type, treatment type, end user and region. By type the market is categorized into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. Depending on treatment type, it is fragmented into wound care dressing, wound care devices and others. On the basis of end user, it is divided into hospitals, homecare and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
COVID-19 Impact Analysis
Coronavirus Severe acute respiration syndrome (SARS-CoV-2) is an infectious disease caused by the novel coronavirus (COVID-19), which originated in the Wuhan district in China in the late 2019, and since has spread to 212 countries. The virus was initially referred to as “novel coronavirus 2019” (2019-nCoV) by the WHO, However, on February 11, 2020, it was given the official name of SARS-CoV-2 by the International Committee on Taxonomy of Viruses. WHO declared COVID-19 as pandemic on March 11, 2020, and by September 1, 2020, over 28.1 million people were infected globally with over 909,000 deaths. COVID-19 symptoms include fever, cough, and shortness of breath. In January 2021, the DCGI announced approval of COVAXIN for emergency use to prevent COVID-19. Meanwhile, in January 2021, AstraZeneca, a global biopharmaceutical company, announced approval of AstraZeneca COVID-19 vaccine for prevention of COVID-19.
Nearly all industries have been impacted by the global public health epidemic COVID-19. The healthcare organizations had to devote the majority of their funds to fighting COVID-19, the outbreak of COVID-19 has resulted in a significant decline in demand for the pressure ulcer treatments across several sectors, particularly the health and pharmaceutical sector which negatively affect pressure ulcers industry. As a result, the COVID-19 outbreak will slow global market growth for pressure ulcer treatment, which had a negative effect on the market's value in 2020 and beyond.
Global Pressure Ulcers Market by Type
By type, the stage 1 was the major shareholder in 2021 owing to, increase in count of stage 1 injuries which also increases adoption of pressure ulcer treatment. However, stage 2 segment is expected to register Fastest CAGR during forecast period and drive pressure ulcers market growth. This is attributed to the growth in number of patients with stage 2 pressure ulcer. For instance, according to American Journal of Critical Care, in 2020, the incidence rate for stage 2 pressure ulcer is 45%.
Stage 1 dominated the market in 2021
Global Pressure Ulcers Market by Treatment Type
Based on treatment type, the wound care devices segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period. this is attributed to the increase in adoption of advanced wound dressings for the treatment of pressure ulcer wounds. In addition, effective product range launched by companies ensuring better therapeutic outcomes as compared to traditional methods has further boosted the market. For instance, the Kitasato University developing wound dressing composed of collagen sponge having epidermal growth factors and vitamin-C derivatives and hyaluronic acid. On the other side, wound care devices segment is expected to register highest CAGR of 5.6% during pressure ulcers market forecast. This attributed to the technological advancements in wound care devices and shift in inclination toward homecare therapies.
By Treatment Type
Wound Care Dressing segment dominated the market in 2021.
Global Pressure Ulcers Market by End User
By end user, the hospitals segment was the major shareholder 2021 and anticipated to continue this trend during the forecast period. This is attributed to the fact that hospital are increasingly showing an inclination toward advanced wound care products. In addition, increase in investments by hospitals in advanced wound care products to reduce hospital stay and to curb the overall cost burden by minimizing longer hospital stay of patients significantly contribute toward the growth of the global market. However, homecare segment is expected to register fastest CAGR during forecast period. This is attributed to the availability and quality of protocols for pressure ulcer prevention in homecare setting.
By End User
The Hospitals segment dominated the market in 2021.
Global Pressure Ulcers Market by Region
By region, the pressure ulcers market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America has the highest pressure ulcers market share in 2021, and is expected to maintain its lead during the forecast period, owing to presence of advanced healthcare facilities with trained medical professionals, increase in R&D activities to develop advanced wound care products, presence of key players, and surge in investment made by government in the healthcare system. However, Asia-Pacific is expected to register fastest CAGR during forecast period, owing to rise in incidence of pressure ulcers, high disposable income, increase in patient awareness toward advanced wound care products, and surge in demand for advanced wound care products.
North America dominated the market in 2021 and is expected to grow at a CAGR of 3.4%.
Major key players that operate in the global pressure ulcers market are 3M, Abercrombie & Fitch Co (Hollister), Anhui Jinye Industrial Co., Ltd., B. Braun Melungeon AG, Baxter International (Hill-Rom Holdings, Inc), Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity (BSN medical), Integra LifeSciences (Derma Sciences Inc), Investor AB (Mölnlycke Healthcare AB), Johnson and Johnson, Shandong Chuangkang Biotechnology Co., Ltd., Smith & Nephew plc, Stryker, Tissue Regenix and Wego Group (Foosin Medical Supplies Inc., Ltd.).
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pressure ulcers market analysis from 2021 to 2031 to identify the prevailing pressure ulcers market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pressure ulcers market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pressure ulcers market trends, key players, market segments, application areas, and market growth strategies.
Pressure Ulcers Market Report Highlights
Market Size By 2031
USD 5.6 billion
CAGR of 4.2%
2021 - 2031
By Treatment Type
By End user
Key Market Players
ConvaTec Group Plc, Cardinal Health Inc., Smith & Nephew plc, Tissue Regenix, Wego Group (Foosin Medical Supplies Inc., Ltd.), Coloplast Group, Abercrombie & Fitch Co (Hollister), Integra LifeSciences (Derma Sciences Inc), Stryker Corporation, Investor AB (Mölnlycke Healthcare AB), Essity (BSN medical), J&J, Baxter International (Hill-Rom Holdings, Inc), Anhui Jinye Industrial Co., Ltd, Shandong Chuangkang Biotechnology Co., Ltd., 3M Company, B. Braun Melungeon AG
The global pressure ulcers market is expected to exhibit high growth potential attributable to factors such as increase in prevalence of pressure ulcer conditions, rise in R&D activities in pharmaceutical industry for manufacturing of novel wound care dressings and surge in number of approvals by the U.S. food and Drug Administration (FDA) for pressure ulcer wound dressings and devices. Moreover, increase in prevalence of pressure ulcer among geriatric population with conditions such as immobility, paralysis and other chronic diseases contributes toward the growth of the market.
North America is expected to witness the highest growth, in terms of revenue, owing to rise in prevalence of pressure ulcers, increase in patients seeking treatments for pressure ulcers, and strong presence of key players.